Safety and Tolerability of Dalcetrapib in High-Risk Patients with Type 2 Diabetes and/or Metabolic Syndrome
Anne Carol Goldberg, Anton F.H. Stalenhoef, Regina Duttlinger-Maddux, David KallendVolume:
3
Year:
2009
Language:
english
DOI:
10.1016/j.jacl.2009.04.025
File:
PDF, 275 KB
english, 2009